Skip to main content
. 2017 Mar 9;18:62–72. doi: 10.1016/j.ebiom.2017.03.012

Fig. 5.

Fig. 5

Overexpression of DHX32 is associated with tumor angiogenesis and poor prognosis of CRC patients. (a) Representative images and statistical analyses of DHX32, CD31 and β-catenin expressions in CRC tissues and adjacent non-tumor tissues. (b) Summary of the differences in the expression of DHX32 protein, CD31 and β-catenin protein between paired CRC and adjacent non-tumor tissues. (c) Correlation between DHX32 protein levels and CD31 in CRC tissues. (d) Statistical analyses of the association between DHX32 and CD31 expressions as well as DHX32 and β-catenin. (e) Representative images and statistical analyses of DHX32 expressions in different histologic grade samples. (f & g) Statistical analyses of the association of DHX32 expression with overall survival time (f) and metastasis free survival time (g) of CRC patients. N, Adjacent non-tumor control; T, Tumor; r, Pearson correlation coefficient; *P < 0.05, **P < 0.01. The scale bars indicate 100 μm.